Skip to content
Tenfell
Awarded contract
Published 04 Dec 2025

NHS National Framework for Denosumab Injection commencing 1st January 2026

NHS England · London

Key facts

Awarded
05 Nov 2025
Contract starts
01 Jan 2026
Contract ends
31 Dec 2026
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 7 suppliers

SupplierValue
Teva UK Ltd—
Accord-UK Ltd—
Celltrion Healthcare United Kingdom Limited—
Gedeon Richter UK Ltd—
Zentiva Pharma UK Ltd—
FRESENIUS KABI LIMITED—
Amgen Ltd—

Description

Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months) CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/12/2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.